Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Source wikipedia By NASA - https://www.wunderground.com/cat6/strange-days-ex-hurricane-ophelia-batters-ireland-under-orange-skies, Public Domain, https://commons.wikimedia.org/w/index.php?curid=63423067

Ex-Hurricane Ophelia & Ireland-based manufacturing: Pfizer, Roche & Takeda update

Storm Ophelia hit the Green Isle this week, forcing the closure of schools, public institutions, and a number of drug manufacturing sites across the country.

BioProduction 2017 on the Green Isle: Live updates from Dublin

Despite a hurricane warning and nationwide lockdown, Biopharma-Reporter has weathered the Ophelia Storm. We are in Dublin, Ireland for the BioProduction Congress 2017, to report on all things single-use, mammalian and microbial, and the future of biomanufacturing.

GSK taps Plasticell's stem cell differentiation tech

GSK will look to optimise its induced pluripotent stem cell (iPSC) differentiation processes through collaboration with high throughput tech firm Plasticell.

'Luxturna' recommendation good for all AAV based gene therapies says advocacy group

The US approval recommendation for Spark Therapeutics’ blindness gene therapy voretigene neparvovec is also an endorsement of AAV delivery technologies according to the Alliance for Regenerative Medicine.

Amgen: Industry must look to next-generation continuous cell harvesting tech

Amgen says it is evaluating Pall’s Cadence Acoustic Separation as a primary cell clarification method for monoclonal antibodies.

VirionHealth secures Abingworth backing to trial novel antiviral studies

VirionHealth Ltd is poised to start Phase I trials of new biological antivirals - called defective interfering particles - after receiving £13m ($15m) from private equity group Abingworth.